With 14.69 million shares changed hands, the volume of the stock remained heavier than its average volume of 11.95 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $78.99 whereas the lowest price it dropped to was $70.5. The 52-week range on TEM shows that it touched its highest point at $91.45 and its lowest point at $31.36 during that stretch. It currently has a 1-year price target of $70.00. Beta for the stock currently stands at 5.06.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TEM was up-trending over the past week, with a rise of 28.99%, but this was up by 28.65% over a month. Three-month performance surged to 19.79% while six-month performance fell -12.29%. The stock gained 132.38% in the past year, while it has gained 82.87% so far this year. A look at the trailing 12-month EPS for TEM yields -1.18 with Next year EPS estimates of -0.09. For the next quarter, that number is -0.18. This implies an EPS growth rate of 51.90% for this year and 88.49% for next year.
Float and Shares Shorts:
At present, 168.58 million TEM shares are outstanding with a float of 93.22 million shares on hand for trading. On 2025-07-31, short shares totaled 23.17 million, which was 1335.0001 higher than short shares on 1751241600. In addition to Mr. Eric P. Lefkofsky J.D. as the firm’s Co-Founder, CEO, President & Chairman, Mr. Ryan Fukushima serves as its Chief Operating Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, TEM reported revenue of $314635000.0 and operating income of -$61774000.0. The EBITDA in the recently reported quarter was $9080000.0 and diluted EPS was -$0.25.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TEM since 6 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With TEM analysts setting a high price target of 80.0 and a low target of 60.0, the average target price over the next 12 months is 70.0. Based on these targets, TEM could surge 1.98% to reach the target high and fall by -23.52% to reach the target low. Reaching the average price target will result in a decline of -10.77% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.30504 being high and -$2.37703 being low. For TEM, this leads to a yearly average estimate of -$1.75947. The surprise factor in the prior quarter was -$0.27. Based on analyst estimates, the high estimate for the next quarter is $0.0 and the low estimate is -$0.46. The average estimate for the next quarter is thus -$0.12.
